The global autologous cell therapy market size was valued at USD 5.2 billion in 2021 and is poised to grow at a significant CAGR of 19.2% during the forecast period 2022-28. Autologous cell therapy (also recognised as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is stem-cell transplantation in which indistinct cells or stem cells (cells from which other cell types...